Komori
Revision of earnings forecasts3645Medical Net,Inc.Information and Communications, Services and Others

Summary of Financial Results for the Fiscal Year Ended May 2024 [Japanese GAAP] (Consolidated)

The consolidated results for the fiscal year ended May 2024 were finalized. Revenue increased, while operating profit, ordinary profit and net profit attributable to owners of the parent declined. The Company also newly presented earnings forecasts for the cumulative second quarter and full year of the fiscal year ending May 2025.

Worth reading
83Important
Scored from 3 of 5 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Avoiding a definitive answer
How definitive the wording is.

Revised forecast

2025年5月期 · Six months and full year
Net Sales—→—million
—
Operating profit—→—million
—
Ordinary income—→—million
—
Profit attributable to owners of the parent—→—million
—
Net income per share—→—yen
—

The bar length represents the relative magnitude of change, based on the item that changed the most in this document.

Reason for the revision

事業拡大により売上高が増加した一方、株式会社ミルテルの収益化未実現および事業拡大に伴う人件費増加により営業利益が減少した。

Details and amount of extraordinary loss

投資有価証券評価損4,269千円、減損損失170,812千円、特別損失合計175,082千円

Previous-period results2024年5月期実績:売上高5,252百万円、営業利益298百万円、経常利益322百万円、親会社株主に帰属する当期純利益5百万円、1株当たり当期純利益0.66円
Dividend forecast revision2025年5月期の年間配当予想は3.00円(期末3.00円)。修正の明示なし。
Consolidated / non-consolidatedConsolidated
Revised forecast
ItemDetails
Net SalesNot disclosed → Cumulative second-quarter results 3,088 / Full year 6,400
Operating profitNot disclosed → Cumulative second-quarter results 80 / Full year 330
Ordinary incomeNot disclosed → Cumulative second-quarter results 67 / Full year 305
Profit attributable to owners of the parentNot disclosed → Cumulative second-quarter results -5 / Full year 136
Net income per shareNot disclosed → Cumulative second-quarter results -0.58 / Full year 19.95
Fiscal Period Covered2025年5月期
Period CoveredSix months and full year
Previous-period results2024年5月期実績:売上高5,252百万円、営業利益298百万円、経常利益322百万円、親会社株主に帰属する当期純利益5百万円、1株当たり当期純利益0.66円
Reason for the revision事業拡大により売上高が増加した一方、株式会社ミルテルの収益化未実現および事業拡大に伴う人件費増加により営業利益が減少した。
Details and amount of extraordinary loss投資有価証券評価損4,269千円、減損損失170,812千円、特別損失合計175,082千円
Dividend forecast revision2025年5月期の年間配当予想は3.00円(期末3.00円)。修正の明示なし。
Consolidated / non-consolidatedConsolidated
Items this document does not state (1)
Publication date of previous forecast

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

事業拡大により売上高が増加した一方、2024年1月に連結子会社化した株式会社ミルテルが成長過程にあり収益化できていないこと、事業拡大に伴う人員増加で人件費が増えたことにより営業利益が減少しました。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the Fiscal Year Ended May 2024 [Japanese GAAP] (Consolidated) | Medical Net,Inc. (3645) timely disclosure | Komori